BREAST ATYPICAL DUCTAL HYPERPLASIA

Clinical trials for BREAST ATYPICAL DUCTAL HYPERPLASIA explained in plain language.

Never miss a new study

Get alerted when new BREAST ATYPICAL DUCTAL HYPERPLASIA trials appear

Sign up with your email to follow new studies for BREAST ATYPICAL DUCTAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Could a lower tamoxifen dose cut breast cancer risk? new trial seeks answers

Prevention Recruiting now

This study tests whether a low dose of tamoxifen can safely reduce breast density—a key risk factor for breast cancer—in premenopausal women at higher-than-average risk. About 200 women will receive a response-guided dose, with adjustments based on how their breast density change…

Matched conditions: BREAST ATYPICAL DUCTAL HYPERPLASIA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention

Last updated May 17, 2026 02:03 UTC

BREAST ATYPICAL DUCTAL HYPERPLASIA

Get alerted when new BREAST ATYPICAL DUCTAL HYPERPLASIA trials appear

Could a lower tamoxifen dose cut breast cancer risk? new trial seeks answers